Dr Reddys Laboratories Ltd's share price has fallen by -2.06%, presenting both challenges and opportunities for investors. As of now, it's trading at 1190.50, and market participants are assessing the implications. The stock has a PE ratio of 17.6800, an ROE of 16.0277 and a debt to equity ratio of 0.1625.







